← Back to Search

Other

Wave-CAIPI for Low Grade Glioma

N/A

Recruiting

Led By Kawin Setsompop, PhD

Research Sponsored by Boston Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Infants, children and adults who have been diagnosed with Low Grade Glioma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is testing a new software to improve MRI accuracy and image processing.

Who is the study for?

This trial is for infants, children, and adults diagnosed with Low Grade Glioma (LGG), as well as healthy volunteers of any age. Participants must be receiving treatment at DFCI to qualify.Check my eligibility

What is being tested?

The study is testing a new software called Wave-CAIPI designed to improve MRI systems and the processing of MR images. It aims to develop faster imaging techniques specifically for pediatric use.See study design

What are the potential side effects?

Since this trial involves non-invasive MRI technology using investigational software, there are no direct side effects like those seen with medications; however, discomfort or anxiety from being in an MRI machine may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Low Grade Glioma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Wave-CAIPI validation

Trial Design

2Treatment groups

Experimental Treatment

Group I: Software Testing GroupExperimental Treatment1 Intervention

Participants will receive hour research-only scan Wave-CAIPI will be use to enable a 40-60 s acquisition per contrast at 0.9-mm isotropic resolution Wave-CAIPI will be used to acquire a 4-echo GE-SE time-series at 1.5-mm isotropic resolution

Group II: Primary Testing GroupExperimental Treatment1 Intervention

This scan is in the same imaging session as the participant's scheduled clinical MRI and is no longer 15 minutes Wave-CAIPI will be use to enable a 40-60 s acquisition per contrast at 0.9-mm isotropic resolution Wave-CAIPI will be used to acquire a 4-echo GE-SE time-series at 1.5-mm isotropic resolution

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor

761 Previous Clinical Trials

5,579,430 Total Patients Enrolled

Dana-Farber Cancer InstituteOTHER

1,079 Previous Clinical Trials

340,648 Total Patients Enrolled

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH

89 Previous Clinical Trials

19,484 Total Patients Enrolled

Media Library

Wave-CAIPI (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03761121 — N/A

Low Grade Glioma Research Study Groups: Primary Testing Group, Software Testing Group

Low Grade Glioma Clinical Trial 2023: Wave-CAIPI Highlights & Side Effects. Trial Name: NCT03761121 — N/A

Wave-CAIPI (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03761121 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this study available to potential participants currently?

"Affirmative, clinicaltrials.gov hosts information which confirms that this medical study is actively recruiting members of the public. This trial was initially posted on April 15th 2019 and underwent its most recent update on June 12th 2023. 300 volunteers across 3 different sites need to be recruited for this research project."

Answered by AI

What is the scope of participation in this clinical trial?

"Yes, the clinical trial is still actively enrolling patients. According to information hosted on clinicialtrials.gov, it was initially published on April 15th 2019 and updated as recently as June 12th 2023. Presently, 300 participants must be recruited from 3 separate medical sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Developing Fast Pediatric Imaging

Ellen Grant 2019. "Developing Fast Pediatric Imaging". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03761121.